{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T06:25:52Z","timestamp":1767162352910},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.ijrobp.2006.11.033","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T07:07:29Z","timestamp":1170918449000},"page":"1323-1331","source":"Crossref","is-referenced-by-count":5,"title":["A Phase II Multi-institutional Trial of Chemoradiation Using Weekly Docetaxel and Erythropoietin for High-Risk Postoperative Head and Neck Cancer Patients"],"prefix":"10.1016","volume":"67","author":[{"given":"Christopher D.","family":"Willey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Netterville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian B.","family":"Burkey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Shyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashar","family":"Shakhtour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Kish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Raben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John I.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine A.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Cmelak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2006.11.033_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib2","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1073\/pnas.77.3.1561","article-title":"Taxol stabilizes microtubules in mouse fibroblast cells","volume":"77","author":"Schiff","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib4","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1200\/JCO.1994.12.7.1458","article-title":"Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis","volume":"12","author":"Tomiak","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib5","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1200\/JCO.1993.11.5.950","article-title":"Phase I clinical trial of Taxotere administered as either a 2-hour or 6-hour intravenous infusion","volume":"11","author":"Burris","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib6","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/1097-0142(19930601)71:11<3774::AID-CNCR2820711147>3.0.CO;2-0","article-title":"Investigation of taxol as a potential radiation sensitizer","volume":"71","author":"Choy","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0360-3016(92)90888-O","article-title":"Taxol: a novel radiation sensitizer","volume":"22","author":"Tishler","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib8","first-page":"1842","article-title":"Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells","volume":"56","author":"Hennequin","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib9","first-page":"1613","article-title":"Differing responses to radiation of murine bone marrow stem cells in relation to the cell cycle","volume":"31","author":"Chaffey","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib10","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1038\/sj.onc.1204487","article-title":"Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1\/G2 arrest instead of mitotic arrest: Molecular determinants of paclitaxel-induced cytotoxicity","volume":"20","author":"Giannakakou","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib11","first-page":"816","article-title":"Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death","volume":"56","author":"Jordan","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib12","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1158\/1078-0432.CCR-0842-03","article-title":"Comparative pharmacokinetics of weekly and every-three-weeks docetaxel","volume":"10","author":"Baker","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib13","first-page":"4751","article-title":"Advanced head and neck cancer and clinical experience of an effective new agent: Docetaxel","volume":"18","author":"Schoffski","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib14","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1200\/JCO.1996.14.5.1672","article-title":"Docetaxel: An active drug for squamous cell carcinoma of the head and neck","volume":"14","author":"Dreyfuss","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1008360323986","article-title":"Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"10","author":"Schoffski","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cncr.11063","article-title":"Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck\u2014The Dana Farber Cancer Institute experience","volume":"97","author":"Haddad","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bjc.6600685","article-title":"Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck","volume":"88","author":"Posner","year":"2003","journal-title":"British J Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.seminoncol.2003.11.017","article-title":"Docetaxel with concurrent radiotherapy in head and neck cancer","volume":"30","author":"Nabell","year":"2003","journal-title":"Semin Oncol"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2006.11.033_bib19","volume":"22","author":"Vermorken","year":"2004","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.ijrobp.2006.11.033_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.10-90003-11","article-title":"Paradigm shift in the treatment of head and neck cancer: The role of neoadjuvant chemotherapy","volume":"10","author":"Posner","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jjco\/hyi058","article-title":"Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications","volume":"35","author":"Kodaira","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib22","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/annonc\/mdh349","article-title":"A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer","volume":"15","author":"Tabernero","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/annonc\/mdi018","article-title":"Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)","volume":"16","author":"Gervais","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib24","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/sj.bjc.6602241","article-title":"A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer","volume":"91","author":"Gridelli","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0360-3016(93)90536-5","article-title":"Erythropoietin increases hemoglobin in cancer-patients during radiation-therapy","volume":"27","author":"Lavey","year":"1993","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(99)00102-4","article-title":"Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome","volume":"53","author":"Brizel","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2004.07.710","article-title":"Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer","volume":"61","author":"Prosnitz","year":"2005","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib28","first-page":"447","article-title":"6th interim analysis of a prospective, randomized, open and controlled AGO- and NOGGO-intergroup study sequential adjuvant chemo-radiotherapy with vs. without epoetin alfa for patients with high risk cervical cancer","volume":"22","author":"Blohmer","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/cncr.11616","article-title":"Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy","volume":"98","author":"Shasha","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib30","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/cncr.21042","article-title":"Epoetin-alpha during radiotherapy for stage III esophageal carcinoma","volume":"103","author":"Rades","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib31","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0360-3016(98)00321-6","article-title":"Continuous hyperfractionated accelerated radiotherapy with\/without mitomycin C in head and neck cancer","volume":"42","author":"Dobrowsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-8140(00)00233-4","article-title":"Continuous hyperfractionated accelerated radiotherapy with\/without mitomycin C in head and neck cancers","volume":"57","author":"Dobrowsky","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib34","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib35","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0360-3016(03)01370-1","article-title":"Radiotherapy with concomitant weekly docetaxel for Stages III\/IV oropharynx carcinoma","volume":"58","author":"Calais","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib37","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.1996.14.3.838","article-title":"Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region","volume":"14","author":"El-Sayed","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/bjc.1995.17","article-title":"An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer","volume":"71","author":"Munro","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0889-8588(05)70091-5","article-title":"Meta-analyses in head and neck squamous cell carcinoma","volume":"13","author":"Bourhis","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib40","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canrad.2004.11.002","article-title":"[Individual patient data meta-analyses in head and neck carcinoma: what have we learnt?]","volume":"9","author":"Pignon","year":"2005","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1634\/theoncologist.10-3-215","article-title":"Chemoradiation after surgery for high-risk head and neck cancer patients: How strong is the evidence?","volume":"10","author":"Bernier","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.1996.14.2.600","article-title":"Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas","volume":"14","author":"Glantz","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.1998.16.2.735","article-title":"Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck","volume":"16","author":"Brockstein","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib45","first-page":"28","article-title":"Combined modality therapy in non\u2013small cell lung and esophageal cancer: A phase I dose-escalation study of docetaxel with concurrent radiotherapy","volume":"25","author":"Vokes","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib46","first-page":"34","article-title":"Concurrent paclitaxel and radiation therapy for breast cancer","volume":"9","author":"Formenti","year":"1999","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib47","first-page":"1931","article-title":"Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non\u2013small cell lung cancer","volume":"4","author":"Choy","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0959-8049(97)10101-0","article-title":"Weekly docetaxel and concomitant boost radiotherapy for non\u2013small cell lung cancer","volume":"34","author":"Koukourakis","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1200\/JCO.1998.16.1.159","article-title":"Phase I study of docetaxel with concomitant thoracic radiation therapy","volume":"16","author":"Mauer","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib50","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.1998.16.4.1331","article-title":"Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: A Phase I\/II trial","volume":"16","author":"Colevas","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib51","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.1999.17.11.3503","article-title":"Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck","volume":"17","author":"Colevas","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib52","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1200\/JCO.2001.19.4.1096","article-title":"Multicenter Phase I\u2013II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck","volume":"19","author":"Posner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000421-200204000-00010","article-title":"Phase I\/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)","volume":"25","author":"Colevas","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/cncr.10661","article-title":"Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck","volume":"95","author":"Shin","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib55","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/1097-0142(20010301)91:5<940::AID-CNCR1083>3.0.CO;2-A","article-title":"Induction paclitaxel and carboplatin for patients with head and neck carcinoma","volume":"91","author":"Dunphy","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1634\/theoncologist.8-1-35","article-title":"Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment","volume":"8","author":"Haddad","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib57","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","article-title":"Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer","volume":"23","author":"Hitt","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00130404-200601000-00011","article-title":"Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer","volume":"12","author":"Allal","year":"2006","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib59","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/cncr.10873","article-title":"A Phase I\/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck","volume":"95","author":"Tishler","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10147-003-0375-z","article-title":"Phase I\/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck","volume":"9","author":"Fujii","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcms.2005.09.003","article-title":"Maximized combined modality treatment of an unselected population of oral and oropharyngeal cancer patients","volume":"34","author":"Kovacs","year":"2006","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/jcms.2002.0283","article-title":"Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel\u2014three year results of a pilot study","volume":"30","author":"Kovacs","year":"2002","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/jjco\/hyg054","article-title":"Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer","volume":"33","author":"Suzuki","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00066-005-1272-3","article-title":"Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer","volume":"181","author":"Kovacs","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib65","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ijrobp.2006.02.010","article-title":"Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck","volume":"65","author":"Tishler","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib66","first-page":"13","article-title":"The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck","volume":"27","author":"Posner","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib67","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00000421-200106000-00003","article-title":"Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer","volume":"24","author":"Janinis","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cncr.21579","article-title":"Weekly docetaxel in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck","volume":"106","author":"Hitt","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib69","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00001813-199603000-00006","article-title":"Paclitaxel sensitizes multidrug resistant cells to radiation","volume":"7","author":"Mote","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib70","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0360-3016(97)00454-9","article-title":"Pharmacokinetic monitoring and dose modification of etanidazole in the RTOG 85\u201327 phase III head and neck trial","volume":"39","author":"Riese","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib71","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0360-3016(98)00348-4","article-title":"Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85\u201327","volume":"42","author":"Lee","year":"1998","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib72","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1200\/JCO.1995.13.8.2077","article-title":"Pretreatment hemoglobin level influences local-control and survival of T1-T2 squamous-cell carcinomas of the glottic larynx","volume":"13","author":"Fein","year":"1995","journal-title":"J Clinical Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib73","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0360-3016(86)90058-1","article-title":"Primary radiotherapy of larynx and pharynx carcinoma\u2014an analysis of some factors influencing local-control and survival","volume":"12","author":"Overgaard","year":"1986","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2006.11.033_bib74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000083130","article-title":"Standard of care for cancer-related anemia: Improving hemoglobin levels and quality of life","volume":"68","author":"Cortesi","year":"2005","journal-title":"Oncology"},{"issue":"Suppl 5","key":"10.1016\/j.ijrobp.2006.11.033_bib75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1634\/theoncologist.9-90005-55","article-title":"rHuEPO and treatment outcomes: The clinical experience","volume":"9","author":"Hudis","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib76","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib77","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(03)01163-X","article-title":"Breast cancer trial with erythropoietin terminated unexpectedly","volume":"4","author":"Leyland-Jones","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib78","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","article-title":"Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Littlewood","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijrobp.2005.04.049","article-title":"Anemia, tumor hypoxemia, and the cancer patient","volume":"63","author":"Varlotto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib80","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF02716548","article-title":"Erythropoietin in cancer treatment: considerations about Henke\u2019s article","volume":"7","author":"Biete Sola","year":"2005","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0140-6736(03)15183-5","article-title":"Erythropoietin to treat anaemia in patients with head and neck cancer","volume":"363","author":"Kaanders","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib82","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(03)15185-9","article-title":"Erythropoietin to treat anaemia in patients with head and neck cancer","volume":"363","author":"Leyland-Jones","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2006.11.033_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2004.06.031","article-title":"Definitive radiotherapy +\/\u2212 erythropoietin for squamous cell carcinoma of the head and neck: Preliminary report of RTOG 99\u201303","volume":"60","author":"Machtay","year":"2004","journal-title":"Int J Radiat Oncol Biol Physics"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606035048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606035048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T06:25:12Z","timestamp":1547015112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301606035048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0360301606035048"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2006.11.033","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}